Conference
Renal dysfunction is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction - Findings from the irbesartan in heart failure with preserved Systolic function trial (I-Preserve)
Authors
McMurray JJ; Komajda M; McKelvie R; Zile M; Ptaszynska A; Massie BM; Carson PE
Volume
116
Pagination
pp. 552-552
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
October 16, 2007
Name of conference
80th Annual Scientific Session of the American-Heart-Association
Conference place
Orlando, FL
Conference start date
November 4, 2007
Conference end date
November 7, 2007
Conference proceedings
CIRCULATION
Issue
16
ISSN
0009-7322